Article info
PDFBrief report
What trial participants need to be told about placebo effects to give informed consent: a survey to establish existing knowledge among patients with back pain
- Correspondence to Dr Felicity L Bishop, Centre for Clinical and Community, Applications of Health Psychology, Faculty of Social Human and Mathematical Sciences, Building 44 Highfield Campus, University of Southampton, Southampton SO17 1BJ, UK; F.L.Bishop{at}southampton.ac.uk
Citation
What trial participants need to be told about placebo effects to give informed consent: a survey to establish existing knowledge among patients with back pain
Publication history
- Received September 26, 2016
- Revised April 25, 2017
- Accepted May 14, 2017
- First published June 29, 2017.
Online issue publication
January 04, 2018
Article Versions
- Previous version (4 January 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
Other content recommended for you
- Placebo and nocebo effects and mechanisms associated with pharmacological interventions: an umbrella review
- Placebo effects and the molecular biological components involved
- Sharing online clinical notes with patients: implications for nocebo effects and health equity
- Placebo effects and racial and ethnic health disparities: an unjust and underexplored connection
- Is there a nocebo response that results from disease awareness campaigns and advertising in Australia, and can this effect be mitigated?
- Placebos in chronic pain: evidence, theory, ethics, and use in clinical practice
- Open-label placebo clinical trials: is it the rationale, the interaction or the pill?
- Unethical informed consent caused by overlooking poorly measured nocebo effects
- Informed consent and clinical trials: where is the placebo effect?
- Unhelpful information about adverse drug reactions